Synthesis, Biological Evaluation and Structure-Activity Relationships of Diflapolin Analogues as Dual sEH/FLAP Inhibitors.
Journal
ACS medicinal chemistry letters
ISSN: 1948-5875
Titre abrégé: ACS Med Chem Lett
Pays: United States
ID NLM: 101521073
Informations de publication
Date de publication:
10 Jan 2019
10 Jan 2019
Historique:
received:
11
09
2018
accepted:
29
11
2018
entrez:
19
1
2019
pubmed:
19
1
2019
medline:
19
1
2019
Statut:
epublish
Résumé
A series of derivatives of the potent dual soluble epoxide hydrolase (sEH)/5-lipoxygenase-activating protein (FLAP) inhibitor diflapolin was designed, synthesized, and characterized by
Identifiants
pubmed: 30655948
doi: 10.1021/acsmedchemlett.8b00415
pmc: PMC6331193
doi:
Types de publication
Journal Article
Langues
eng
Pagination
62-66Déclaration de conflit d'intérêts
The authors declare no competing financial interest.
Références
Annu Rev Pharmacol Toxicol. 2005;45:311-33
pubmed: 15822179
J Med Chem. 2005 Oct 20;48(21):6523-43
pubmed: 16220969
Br J Pharmacol. 2007 Oct;152(4):471-80
pubmed: 17704828
J Pharmacol Exp Ther. 2008 Sep;326(3):975-82
pubmed: 18550688
Curr Pharm Des. 2009;15(6):587-600
pubmed: 19199984
Bioorg Med Chem Lett. 2010 Jan 15;20(2):571-5
pubmed: 19969453
Cell. 2010 Mar 19;140(6):935-50
pubmed: 20303881
Chem Rev. 2011 Oct 12;111(10):5922-43
pubmed: 21766791
J Med Chem. 2013 Feb 28;56(4):1777-81
pubmed: 23356879
Basic Clin Pharmacol Toxicol. 2014 Jan;114(1):83-91
pubmed: 24015667
Bioorg Med Chem Lett. 2015 Jul 1;25(13):2607-12
pubmed: 26004579
Br J Clin Pharmacol. 2016 May;81(5):971-9
pubmed: 26620151
J Chem Inf Model. 2016 Apr 25;56(4):747-62
pubmed: 26882208
Equine Vet J. 2017 May;49(3):345-351
pubmed: 27338788
Microbiol Spectr. 2016 Nov;4(6):
pubmed: 27837747
Expert Opin Ther Pat. 2017 May;27(5):607-620
pubmed: 28005436
Sci Rep. 2017 Feb 20;7:42751
pubmed: 28218273
Sci Rep. 2017 Aug 24;7(1):9398
pubmed: 28839250